First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2009-01-26 05:03:05Open Document File Size: 135,07 KBShare Result on FacebookCityCambridge / Leeds / London / Boston / Oxford / /CompanyClinical Outcomes Group / Astra / Wellcome Trust / ICI Pharmaceuticals / Cancer Research UK / /CountryJapan / United States / United Kingdom / /FacilityNational Institute of Health Research Advisory Board / St James’s University Hospital / University of Leeds / National Cancer Research Institute / University of Birmingham / Leeds University / /IndustryTermforensic and medico-legal applications / /MedicalConditionneurodevelopmental and malignant diseases / /OrganizationNational Cancer Research Institute / National Institute of Health Research Advisory Board / Government Office for Science / Government’s Cancer Reform Strategy Advisory Board / International Union against Cancer / St James’s University Hospital / Leeds University / Translational Medicine Board / Academy of Medical Sciences / University of Leeds / Department of Health Ministerial Industry Strategy Group Advisory Panel / UK Clinical Research Collaboration Board / Department of Health / NHS / office for the Strategic Coordination of Health Research / Medical Research Council / Molecular Medicine Unit / University of Birmingham / Molecular Medicine Unit at St James’s University Hospital / /PersonAlex Markham Alex Markham / Alex Markham / /PositionQueen / Chairman / Professor / Chief Executive / Board Director / Professor of Medicine / member / /SocialTag |